Alkermes (ALKS) EV to EBIT (2010 - 2026)
Alkermes' (ALKS) quarterly EV to EBIT came in at 442.58 in Q2 2026, up 1010.21% year-over-year from 39.86 in Q2 2025, and up 497.59% quarter-over-quarter from 111.31 in Q1 2026.
Analysis
Alkermes (ALKS) EV to EBIT (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported EV to EBIT for 17 consecutive years, with 442.58 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to EBIT rose 1010.21% year-over-year to 442.58 in Q2 2026; TTM through Jun 2026 was 69.27, a 599.37% increase from a year earlier, with the FY2025 full-year figure at 13.84, up 48.76% from the prior year.
- EV to EBIT was 442.58 for Q2 2026 at Alkermes, up from 111.31 in the prior quarter.
- Over five years, EV to EBIT peaked at 442.58 in Q2 2026 and troughed at 371.92 in Q1 2023.
- A 5-year average of 25.1 and a median of 33.22 in 2024 frame the typical range for EV to EBIT.
- Across the five-year window, EV to EBIT plunged 162.6% in 2023 and surged 1010.21% in 2026, its largest moves.
- Over 5 years, EV to EBIT stood at 31.89 in 2022, then surged by 121.45% to 70.63 in 2023, then plunged by 65.95% to 24.05 in 2024, then surged by 151.47% to 60.48 in 2025, then jumped by 631.82% to 442.58 in 2026.
- The last three EV to EBIT figures came in at 442.58 (Q2 2026), 111.31 (Q1 2026), and 60.48 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.92 Bn | 626.16 Bn | 17.26 Bn |
| 2 | AbbVie | 441.93 Bn | 435.36 Bn | 12.70 Bn |
| 3 | Merck | 365.88 Bn | 358.74 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn |
| 6 | Sanofi | 52.44 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 8 | Incyte | 25.31 Bn | 20.78 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.45 Bn | 18.78 Bn | 683.80 Mn |
| 10 | Alkermes | 7.57 Bn | 6.91 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 442.58 |
| Mar 31, 2026 | -111.31 |
| Dec 31, 2025 | 60.48 |
| Sep 30, 2025 | 43.13 |
| Jun 30, 2025 | 39.86 |
| Mar 31, 2025 | 330.59 |
| Dec 31, 2024 | 24.05 |
| Sep 30, 2024 | 34.55 |
| Jun 30, 2024 | 28.41 |
| Mar 31, 2024 | 88.54 |
| Dec 31, 2023 | 70.63 |
| Sep 30, 2023 | 42.39 |
| Jun 30, 2023 | 15.58 |
| Mar 31, 2023 | -371.92 |
| Dec 31, 2022 | 31.89 |
| Sep 30, 2022 | -50.93 |
| Jun 30, 2022 | -125.13 |
| Mar 31, 2022 | -141.63 |
| Dec 31, 2021 | 24.96 |
| Sep 30, 2021 | -225.14 |